Washington, United States.
Some pharmacies in the United States will begin offering vaccinations against him COVID-19 as of February 11, as part of efforts to rapidly increase the number of doses applied to civilians.
The White House Response Coordinator for the COVID-19Jeff Zients told reporters that due to supply restrictions, the program will initially target 6,500 pharmacies across the country but will eventually expand to 40,000.
“This will make more places to be vaccinated available to people in their communities and this is an important part of getting vaccinations justified,” he explained.
The program ensures that people can make appointments pharmacy to receive their doses as their priority group is eligible.
More than 32.2 million injections have been used in the country so far, with just under 6 million people already taking the two necessary doses of the vaccinations from Pfizer The Modern, according to official data.
After initial bottlenecks, states are increasing their vaccine delivery rates while the federal government works with manufacturers to try to increase supply.
The government of Biden it has set a target to deliver 150 million doses in the first 100 days, reaching by April.
More than 100 million doses vaccinations against covid-19 were administered in the world almost two months after the start of the first immunization campaigns, according to an AFP balance.
At least 101,317,005 injections took place in at least 77 countries or territories as of Tuesday at 08:00 GMT, according to an AFP count from official sources.
Israel is the most advanced country in the race for immunization. 37% of the population received at least one dose, and one Israeli in five (21%) completed the process with a second dose.
All vaccines currently in circulation in the world require two doses to a immunization optimal.
In high-income countries, as defined by the World Bank, 16% of the world’s population lives, but 65% of all administered doses in the world are concentrated. In addition to Israel, these are North American, European and Gulf countries.
The leading group includes the United Kingdom (9.8 million doses, 13.7% of the population), the United States (32.2 million doses, 7.9%), the United Arab Emirates (3.4 million doses, no data on people) and Serbia (6.2%).
In the European Union (EU), 12.7 million doses were inoculated to 2.3% of the population. Of the 27, Malta is in the lead with 5.4% of the population, followed by Denmark (3.2%) and Poland (3.1%).